Genomics Seminar Series

Tim Ley, M.D., Professor and Associate Director, Genome Institute at Washington University. Dr. Ley is a hematologist, oncologist and cancer biologist. He is an internationally known expert in the pathogenesis of acute myeloid leukemia (AML) and other blood-related disorders. His research group was one of the first to focus on the reference sequence of the human genome to systematically identify the mutations responsible for the initiation and progression of cancer, focusing primarily on AML.